Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Elche (23)

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  3. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2020

  1. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018

2019

  1. Novel molecular characterization of colorectal primary tumors based on mirnas

    Cancers, Vol. 11, Núm. 3

  2. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

2018

  1. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

    International Journal of Epidemiology, Vol. 47, Núm. 2, pp. 473-483

2017

  1. Reduced risk of pancreatic cancer associated with asthma and nasal allergies

    Gut, Vol. 66, Núm. 2, pp. 314-322

2016

  1. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

2010

  1. A polymeric chip for micromanipulation and particle sorting by ultrasounds based on a multilayer configuration

    Sensors and Actuators, B: Chemical, Vol. 144, Núm. 1, pp. 310-317

2009

  1. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis

    International Journal of Cancer, Vol. 124, Núm. 3, pp. 608-613

  2. Utility of p16 immunohistochemistry for the identification of Lynch syndrome

    Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162

2006

  1. Cutaneous metastases of lung cancer

    Clinical and Translational Oncology, Vol. 8, Núm. 5, pp. 330-333

  2. Molecular biology of exocrine pancreatic cancer

    Clinical and Translational Oncology, Vol. 8, Núm. 5, pp. 306-312

2005

  1. Biología molecular del cáncer de páncreas exocrino

    Revisiones en Cancer, Vol. 19, Núm. 1, pp. 12-26

  2. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines

    Molecular Cancer Therapeutics, Vol. 4, Núm. 8, pp. 1222-1230

2000

  1. Occupation and pancreatic cancer in Spain: A case-control study based on job titles

    International Journal of Epidemiology, Vol. 29, Núm. 6, pp. 1004-1013

  2. The 18q21 region in colorectal and pancreatic cancer: Independent loss of DCC and DPC4 expression

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1502, Núm. 2, pp. 283-296

1998

  1. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

    Annals of Oncology, Vol. 9, Núm. 7, pp. 727-731

1997

  1. Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancer

    Lung Cancer, Vol. 17, Núm. 2-3, pp. 261-269